Dyadic International (DYAI) Expected to Announce Quarterly Earnings on Wednesday

Posted by Stanley Muller on May 6th, 2026

Dyadic International (NASDAQ:DYAI – Get Free Report) will likely be announcing its Q1 2026 results after the market closes on Wednesday, May 13th. Analysts expect the company to announce earnings of ($0.04) per share and revenue of $0.9040 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q1 2026 earning report page for the latest details on the call scheduled for Wednesday, May 13, 2026 at 5:00 PM ET.

Dyadic International (NASDAQ:DYAI – Get Free Report) last released its quarterly earnings data on Wednesday, March 25th. The biotechnology company reported ($0.06) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.03). The business had revenue of $0.57 million during the quarter, compared to analysts’ expectations of $1.34 million. Dyadic International had a negative net margin of 239.67% and a negative return on equity of 695.96%. On average, analysts expect Dyadic International to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Dyadic International Stock Up 2.5%

NASDAQ:DYAI opened at $0.77 on Wednesday. The firm has a market capitalization of $28.06 million, a P/E ratio of -3.08 and a beta of 1.18. Dyadic International has a 1-year low of $0.65 and a 1-year high of $1.35. The company’s fifty day moving average price is $0.82 and its 200-day moving average price is $0.90. The company has a debt-to-equity ratio of 4.08, a current ratio of 2.68 and a quick ratio of 2.68.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of DYAI. Bank of America Corp DE lifted its holdings in Dyadic International by 16,146.7% in the fourth quarter. Bank of America Corp DE now owns 27,132 shares of the biotechnology company’s stock valued at $47,000 after acquiring an additional 26,965 shares during the period. Landscape Capital Management L.L.C. acquired a new stake in shares of Dyadic International during the 3rd quarter worth approximately $190,000. Finally, Geode Capital Management LLC increased its holdings in shares of Dyadic International by 13.7% during the 4th quarter. Geode Capital Management LLC now owns 301,673 shares of the biotechnology company’s stock valued at $284,000 after purchasing an additional 36,266 shares in the last quarter. 27.95% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Dyadic International in a report on Friday, March 27th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $3.00.

Read Our Latest Research Report on Dyadic International

Dyadic International Company Profile

(Get Free Report)

Dyadic International, Inc is a biotechnology company headquartered in Jupiter, Florida, that specializes in developing and commercializing its proprietary C1 fungal-based expression platform. The company’s core business revolves around enabling efficient, scalable production of proteins and enzymes for a wide range of applications, including biopharmaceuticals, industrial enzymes, agricultural bioactives and biofuels. By leveraging its C1 system, Dyadic seeks to offer clients cost-effective, high-yield manufacturing processes that can accelerate development timelines and reduce overall production costs.

The Dyadic C1 platform is designed to produce complex proteins five to ten times faster than traditional cell culture technologies, such as CHO cells or yeast.